Latest News From "The Pink Sheet" DAILY

FDA Updates Plavix Label, Leaves Effient With Clear Advantage

FDA expands upon the warning that it discreetly slipped into the anti-clotting drug's labeling in May, with new data that clopidogrel is 50% less effective when given with Prilosec.   read more

 

Is TMS' Cangrelor A CHAMPION After All? "Noise On The Line" Confounded Endpoint Data, CEO Says

Speeding heart attack patients into the PCI lab may have blurred the timeline on their MIs and botched endpoint data, says Meanwell.   read more

 

DeCode Enters Bankruptcy, Looks To Sell Assets To Its Former VCs

Saddled by $314 million in debt, the Icelandic firm files for Chapter 11 protection.   read more

 

Opioid REMS Development Achieves Milestone: Another Public Meeting

FDA will meet with manufacturers on Dec. 4 to discuss progress on developing the safety program.   read more

 

Spiriva Safety Debate Pits Clinical Study Results Against Meta-Analysis

FDA also asks advisory panel to assess mixed efficacy results for BI's drug to reduce exacerbation of chronic obstructive pulmonary disease.   read more

 

Health Care Reform Could Be In Critical Condition If Senate Doesn't Vote By Christmas, Daschle Says

At a Lazard Capital Markets meeting in New York, Daschle gave reform a 60 percent chance, but those odds would decrease if Senate doesn't vote on a bill by Christmas.   read more

 

"The Pink Sheet" DAILY - Daily, in-depth analysis of the key developments shaping the biopharma industry. Not a subscriber? To register for a free trial, click here